Hematopathologic findings in chronic idiopathic myelofibrosis

Seminars in Oncology

Volumn 32, Issue 4, 2005, Pages 380-394

  Thiele, Juergen ^a   Kvasnicka, Hans M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD34 ANTIGEN; HYDROXYUREA; RETICULIN;

ANEMIA; ANGIOGENESIS; APLASIA; APOPTOSIS; BONE MARROW CELL; CELL KINETICS; CELL PROLIFERATION; CHRONIC IDIOPATHIC MYELOFIBROSIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ERYTHROID PRECURSOR CELL; FIBROSIS; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; HYPOPLASIA; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MICROVASCULATURE; MYELOID METAPLASIA; MYELOPHTHISIC ANEMIA; MYELOPROLIFERATIVE DISORDER; OSTEOSCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPLENOMEGALY; STEM CELL; SURVIVAL; SYNTHESIS; THROMBOCYTHEMIA; THROMBOCYTOSIS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 23044440823     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.04.010     Document Type: Article

References (136)

1. J. Laszlo Myeloproliferative disorders (MPD): Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia Semin Hematol 12 1975 409 432
2. G. Barosi, A. Ambrosetti, C. Finelli The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia Br J Haematol 104 1999 730 737
3. F. Cervantes, G. Barosi, J.L. Demory Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk groups Br J Haematol 102 1998 684 690
4. J.I. Dickstein, J.W. Vardiman Hematopathologic findings in the myeloproliferative disorders Semin Oncol 22 1995 355 373
5. A. Tefferi Myelofibrosis with myeloid metaplasia N Engl J Med 342 2000 1255 1265
6. A. Varki, R. Lottenberg, R. Griffith The syndrome of idiopathic myelofibrosis A clinicopathologic review with emphasis on the prognostic variables predicting survival Medicine (Baltimore) 62 1983 353 371
7. G. Barosi Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines J Clin Oncol 17 1999 2954 2970
8. D. Dingli, R.A. Mesa, A. Tefferi Myelofibrosis with myeloid metaplasia: New developments in pathogenesis and treatment Intern Med 43 2004 540 547
9. F. Cervantes, A. Pereira, J. Esteve The changing profile of idiopathic myelofibrosis: A comparison of the presenting features of patients diagnosed in two different decades Eur J Haematol 60 1998 101 105
10. J.W. Vardiman Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases Semin Diagn Pathol 20 2003 154 179
11. J. Thiele, R. Zankovich, T. Steinberg Agnogenic myeloid metaplasia (AMM)-Correlation of bone marrow lesions with laboratory data: A longitudinal clinicopathological study on 114 patients Hematol Oncol 7 1989 327 343
12. J. Thiele, B. Hoeppner, R. Zankovich Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)-Correlations between clinical and morphological features Virchows Arch A Pathol Anat Histopathol 415 1989 191 202
13. J.J. Michiels, J. Thiele Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia) Int J Hematol 76 2002 133 145
14. J.I. Dickstein, J.W. Vardiman Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes Am J Clin Pathol 99 1993 513 525
15. T. Buhr, G. Buesche, H. Choritz Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens Am J Clin Pathol 119 2003 152 158
16. A. Georgii, G. Buesche, A. Kreft The histopathology of chronic myeloproliferative diseases Baillieres Clin Haematol 11 1998 721 749
17. J. Thiele, Y.S. Chen, H.M. Kvasnicka Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis-A histomorphometric study on sequential trephine biopsies Leuk Lymphoma 14 1994 163 169
18. J. Thiele, H.M. Kvasnicka, A. Schmitt-Gräff Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: A follow-up study on 309 patients Leuk Lymphoma 44 2003 549 553
19. J. Thiele, H.M. Kvasnicka, V. Diehl Standardization of bone marrow features-Does it work in hematopathology for histological discrimination of different disease patterns? Histol Histopathol 20 2005 633 644
20. W. Breuer, J. Darbès, W. Hermanns Idiopathic myelofibrosis in a cat and in three dogs Compar Haematol Int 9 1999 17 24
21. J. Thiele, H.M. Kvasnicka, B. Boeltken Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF)-A clinicopathological study Leukemia 13 1999 1741 1748
22. J. Thiele, H.M. Kvasnicka, R. Zankovich Early stage idiopathic (primary) myelofibrosis - current issues of diagnostic features Leuk Lymphoma 43 2002 1035 1041
23. J. Thiele, H.M. Kvasnicka, C. Werden Idiopathic primary osteo-myelofibrosis: A clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact Leuk Lymphoma 22 1996 303 317
24. A. Georgii, T. Buhr, G. Buesche Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies Leuk Lymphoma 22 suppl 1 1996 15 29
25. A. Georgii, K.F. Vykoupil, T. Buhr Chronic myeloproliferative disorders in bone marrow biopsies Pathol Res Pract 186 1990 3 27
26. Thiele J, Kvasnicka HM, Facchetti F, et al: European consensus for grading of bone marrow fibrosis and assessment of cellularity. Haematologica (in press)
27. A. Kreft, J. Reimann, H. Choritz Fibre content and cellularity of the bone marrow of the iliac crest, vertebral column and sternum in chronic myeloproliferative disorders Leuk Lymphoma 38 2000 165 173
28. J. Thiele, A. Laubert, K.F. Vykoupil Autopsy and clinical findings in acute leukemia and chronic myeloproliferative diseases-An evaluation of 104 patients Pathol Res Pract 179 1985 328 336
29. T. Bachleitner-Hofmann, H. Gisslinger The role of interferon-alpha in the treatment of idiopathic myelofibrosis Ann Hematol 78 1999 533 538
30. G. Barosi, C. Berzuini, L.N. Liberato A prognostic classification of myelofibrosis with myeloid metaplasia Br J Haematol 70 1988 397 401
31. L. Parmeggiani, A. Ferrant, J. Rodhain Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia Eur J Haematol 39 1987 228 232
32. S. Sacchi The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): A concise update Leuk Lymphoma 19 1995 13 20
33. J. Thiele, H.M. Kvasnicka, A. Schmitt-Graeff Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis Histopathology 43 2003 470 479
34. H. Hasselbalch, I. Lisse A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis Eur J Haematol 46 1991 285 289
35. E. Loefvenberg, A. Wahlin, G. Roos Reversal of myelofibrosis by hydroxyurea Eur J Haematol 44 1990 33 38
36. A. Manoharan, W.R. Pitney Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis Scand J Haematol 33 1984 453 459
37. J. Thiele, H.M. Kvasnicka, A. Schmitt-Graff Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis Histol Histopathol 19 2004 239 250
38. J. Thiele, M. Imbert, R. Pierre Chronic idiopathic myelofibrosis E.S. Jaffe N.L. Harris H. Stein WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon, France 35 38
39. J. Thiele, R. Windecker, H.M. Kvasnicka Erythropoiesis in primary (idiopathic) osteomyelofibrosis: Quantification, PCNA-reactivity, and prognostic impact Am J Hematol 46 1994 36 42
40. T. Buhr, A. Georgii, H. Choritz Myelofibrosis in chronic myeloproliferative disorders Incidence among subtypes according to the Hannover classification Pathol Res Pract 189 1993 121 132
41. J. Thiele, T.K. Zirbes, H.M. Kvasnicka Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma-A practical guideline J Clin Pathol 52 1999 294 300
42. J. Thiele, H.M. Kvasnicka, B. Boeltken Resident bone marrow macrophages in idiopathic (primary) myelofibrosis (IMF): A histochemical and morphometric study on sequential trephine biopsies Leuk Res 23 1999 983 985
43. J. Thiele, H.M. Kvasnicka Prefibrotic chronic idiopathic myelofibrosis-A diagnostic enigma? Acta Haematol 111 2004 155 159
44. J. Thiele, H.M. Kvasnicka Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features-A clinicopathological study on 272 patients Histol Histopathol 18 2003 93 102
45. J. Thiele, H.M. Kvasnicka Chronic myeloproliferative disorders with thrombocythemia: A comparative study of two classification systems (PVSG, WHO) on 839 patients Ann Hematol 82 2003 148 152
46. J. Thiele, B. Hoeppner, S. Wienhold Osteoclasts and bone remodeling in chronic myeloproliferative disorders A histochemical and morphometric study on trephine biopsies in 165 patients Pathol Res Pract 184 1989 591 599
47. J. Thiele, V. Rompcik, S. Wagner Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: An immunomorphometric study on trephine biopsies of the bone marrow Br J Haematol 80 1992 227 234
48. H.M. Kvasnicka, J. Thiele Bone marrow angiogenesis: Methods of quantification and changes evolving in chronic myeloproliferative disorders Histol Histopathol 19 2004 1245 1260
49. J. Thiele, S. Wagner, H.P. Bertsch Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia) An immunomorphometric study on trephine biopsies Pathol Res Pract 186 1990 589 596
50. A. Grossi, A.M. Vannucchi, D. Rafanelli Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases Am J Hematol 25 1987 371 376
51. Z.C. Han, J. Briere, G. Nedellec Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis Eur J Haematol 40 1988 130 135
52. J.A. Hibbin, O.S. Njoku, E. Matutes Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders Br J Haematol 57 1984 495 503
53. G. Chikkappa, A.L. Carsten, A.D. Chanana Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia Am J Hematol 4 1978 121 131
54. A.M. Gewirtz, E. Bruno, J. Elwell In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man Blood 61 1983 384 389
55. + progenitor cells in idiopathic (primary) myelofibrosis: A comparative quantification between spleen and bone marrow tissue Ann Hematol 81 2002 86 89
56. F. Cervantes, D. Tassies, C. Salgado Acute transformation in nonleukemic chronic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients Acta Haematol 85 1991 124 127
57. G. Finazzi, T. Barbui Treatment of essential thrombocythemia with special emphasis on leukemogenic risk Ann Hematol 78 1999 389 392
58. A. Weinfeld, B. Swolin, J. Westin Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications Eur J Haematol 52 1994 134 139
59. T. Higuchi, S. Okada, H. Mori Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent Cancer 75 1995 471 477
60. E. Loefvenberg, I. Nordenson, A. Wahlin Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease Cancer Genet Cytogenet 49 1990 57 67
61. T.P. Lohmann, E.N. Beckman Progressive myelofibrosis in agnogenic myeloid metaplasia Arch Pathol Lab Med 107 1983 593 594
62. G. Visani, C. Finelli, U. Castelli Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients Br J Haematol 75 1990 4 9
63. S. Rupoli, L. Da Lio, S. Sisti Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival Ann Hematol 68 1994 205 212
64. B. Dupriez, P. Morel, J.L. Demory Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system Blood 88 1996 1013 1018
65. J.T. Reilly, J.A. Snowden, R.L. Spearing Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases Br J Haematol 98 1997 96 102
66. H.M. Kvasnicka, J. Thiele, C. Regn Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis Ann Hematol 78 1999 65 72
67. J. Thiele, J. Lorenzen, B. Manich Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: Naked nuclei in megakaryopoiesis reveal features of para-apoptosis Acta Haematol 97 1997 137 143
68. J. Thiele, B.R. Titius, H.M. Kvasnicka Megakaryopoiesis in chronic myeloproliferative disorders: Immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction Anal Cell Pathol 7 1994 63 75
69. A.V. Hoffbrand, I. Chanarin, S. Kremenchuzky Megaloblastic anaemia in myelosclerosis Q J Med 37 1968 493 516
70. J. Thiele, H.P. Bertsch, L.W. Kracht Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes-A comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions J Pathol 173 1994 5 12
71. H.M. Kvasnicka, J. Thiele, C. Werden Prognostic factors in idiopathic (primary) osteomyelofibrosis Cancer 80 1997 708 719
72. R.A. Mesa, C.A. Hanson, S.V. Rajkumar Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia Blood 96 2000 3374 3380
73. L.G. Lundberg, R. Lerner, P. Sundelin Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity Am J Pathol 157 2000 15 19
74. M.C. Le Bousse-Kerdiles, M.C. Martyre Dual implication of fibrogenetic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis Ann Hematol 68 1999 437 444
75. M.C. Le Bousse-Kerdiles, M.C. Martyre Myelofibrosis: Pathogenesis of myelofibrosis with myeloid metaplasia French INSERM Research Network on Myelofibrosis With Myeloid Metaplasia Springer Semin Immunopathol 21 1999 491 508
76. B. Berse, J.A. Hunt, R.J. Diegel Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts Clin Exp Immunol 115 1999 176 182
77. D. Donovan, J.H. Harmey, D. Toomey TGF beta-1 regulation of VEGF production by breast cancer cells Ann Surg Oncol 4 1997 621 627
78. N. Ferrara Vascular endothelial growth factor Eur J Cancer 32A 1996 2413 2422
79. R. Salcedo, K. Wasserman, H.A. Young Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha Am J Pathol 154 1999 1125 1135
80. S.J. Mandriota, M.S. Pepper Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor J Cell Sci 110 1997 2293 2302
81. F. Di Raimondo, G.A. Palumbo, S. Molica Angiogenesis in chronic myeloproliferative diseases Acta Haematol 106 2001 177 183
82. O. Bock, J. Schlue, U. Lehmann Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression Blood 100 2002 2274 2275
83. B.C. Wolf, R.S. Neiman Myelofibrosis with myeloid metaplasia: Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly Blood 65 1985 803 809
84. B. Arora, C.L. Ho, J.D. Hoyer Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia Haematologica 89 2004 1454 1458
85. M. Apaja-Sarkkinen, H. Autio-Harmainen, M. Alavaikko Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis Br J Haematol 63 1986 571 580
86. I. Lisse, H. Hasselbalch, P. Junker Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases An immunohistochemical study Apmis 99 1991 171 178
87. J.T. Reilly, J.R. Nash, M.J. Mackie Endothelial cell proliferation in myelofibrosis Br J Haematol 60 1985 625 630
88. D. Van Dyke, H. Parker, H.O. Anger Markedly increased bone blood flow in myelofibrosis J Nucl Med 12 1971 506 512
89. P. Charbord Increased vascularity of bone marrow in myelofibrosis Br J Haematol 62 1986 595 596
90. G. Barosi, A. Grossi, B. Comotti Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia Br J Haematol 114 2001 78 83
91. D. Bonn Thalidomide: No benefit in myelofibrosis with myeloid metaplasia Lancet Oncol 4 2003 70
92. L. Canepa, F. Ballerini, R. Varaldo Thalidomide in agnogenic and secondary myelofibrosis Br J Haematol 115 2001 313 315
93. M.A. Elliott, R.A. Mesa, C.Y. Li Thalidomide treatment in myelofibrosis with myeloid metaplasia Br J Haematol 117 2002 288 296
94. P.P. Piccaluga, G. Visani, S.A. Pileri Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia A pilot study Leukemia 16 2002 1609 1614
95. J. Cortes, H. Kantarjian Beyond chronic myelogenous leukemia: Potential role for imatinib in Philadelphia-negative myeloproliferative disorders Cancer 100 2004 2064 2078
96. H.C. Hasselbalch, O.W. Bjerrum, B.A. Jensen Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis Am J Hematol 74 2003 238 242
97. A. Tefferi, R.A. Mesa, L.A. Gray Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia Blood 99 2002 3854 3856
98. + stem cells in chronic myeloproliferative disorders Histol Histopathol 17 2002 507 521
99. B.C. Wolf, R.S. Neiman Hypothesis: Splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia Hematol Pathol 1 1987 77 80
100. H.S. Gilbert, V. Praloran, E.R. Stanley Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: Association with myeloid metaplasia and peripheral bone marrow extension Blood 74 1989 1231 1234
101. S. Partanen, T. Ruutu, E. Juvonen Effect of splenectomy on circulating haematopoietic progenitors in myelofibrosis Scand J Haematol 37 1986 87 90
102. J.J. Kirshner, J. Goldberg, S.A. Landaw The spleen as a site of colony-forming cell production in myelofibrosis Proc Soc Exp Biol Med 165 1980 279 282
103. + cells in myelofibrosis with myeloid metaplasia Blood 98 2001 3249 3255
104. L. Douay, J.P. Laporte, G. Lefrancois Blood and spleen haematopoiesis in patients with myelofibrosis Leuk Res 11 1987 725 730
105. S. Partanen, T. Ruutu, P. Vuopio Circulating haematopoietic progenitors in myelofibrosis Scand J Haematol 29 1982 325 330
106. P.A. Chervenick Increase in circulating stem cells in patients with myelofibrosis Blood 41 1973 67 71
107. D. Douer, I. Fabian, M.J. Cline Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders Br J Haematol 54 1983 373 381
108. E.J. Battegay, C. Thomssen, C. Nissen Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders Eur J Haematol 42 1989 321 326
109. D.S. Krause, M.J. Fackler, C.I. Civin CD34: structure, biology, and clinical utility Blood 87 1996 1 13
110. B. Andreasson, B. Swolin, J. Kutti Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia Eur J Haematol 64 2000 188 193
111. B. Andreasson, B. Swolin, J. Kutti Increase of CD34 positive cells in polycythaemia vera Eur J Haematol 59 1997 171 176
112. + cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia Eur J Haematol 68 2002 189 193
113. F. Passamonti, L. Vanelli, L. Malabarba Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders Haematologica 88 2003 1123 1129
114. + myeloid progenitors: Role of marrow stromal, fibroblast, and cytomatrix components Exp Hematol 19 1991 63 70
115. J.C. Wang, C.P. Cheung, F. Ahmed Circulating granulocyte and macrophage progenitor cells in primary and secondary myelofibrosis Br J Haematol 54 1983 301 307
116. J. Thiele, H.M. Kvasnicka, A. Schmitt-Graeff Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patients Am J Hematol 70 2002 283 291
117. M. Imbert, R. Pierre, J. Thiele Essential thrombocythaemia E.S. Jaffe N.L. Harris H. Stein WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues 2001 IARC Press Lyon, France 39 41
118. S. Murphy, P. Peterson, H. Iland Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment Semin Hematol 34 1997 29 39
119. S. Murphy Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia Semin Hematol 36 1999 9 13
120. T.C. Pearson Diagnosis and classification of erythrocytoses and thrombocytoses Baillieres Clin Haematol 11 1998 695 720
121. J. Thiele, H.M. Kvasnicka, V. Diehl Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies Leuk Lymphoma 33 1999 207 218
122. J. Thiele, H.M. Kvasnicka, R. Zankovich Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis Haematologica 85 2000 1126 1134
123. T. Barbui, G. Barosi, A. Grossi Practice guidelines for the therapy of essential thrombocythemia A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation Haematologica 89 2004 215 232
124. C. Annaloro, G. Lambertenghi Deliliers, A. Oriani Prognostic significance of bone marrow biopsy in essential thrombocythemia Haematologica 84 1999 17 21
125. J.T. Ellis, P. Peterson, S.A. Geller Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies Semin Hematol 23 1986 144 155
126. J. Thiele, H.M. Kvasnicka, A. Schmitt-Graeff Acute panmyelosis with myelofibrosis Leuk Lymphoma 45 2004 681 687
127. B. Anger, R. Seidler, U. Haug Idiopathic myelofibrosis: A retrospective study of 103 patients Haematologica 75 1990 228 234
128. A. Manoharan, R.C. Smart, W.R. Pitney Prognostic factors in myelofibrosis Pathology 14 1982 455 461
129. H.C. Hasselbalch Idiopathic myelofibrosis-An update with particular reference to clinical aspects and prognosis Int J Clin Lab Res 23 1993 124 138
130. J.T. Reilly Idiopathic myelofibrosis: Pathogenesis, natural history and management Blood Rev 11 1997 233 242
131. O.S. Njoku, S.M. Lewis, D. Catovsky Anaemia in myelofibrosis: Its value in prognosis Br J Haematol 54 1983 79 89
132. A. Kreft, M. Weiss, B. Wiese Chronic idiopathic myelofibrosis: Prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages A retrospective study identifying subgroups of different prognoses by using the RECPAM method Ann Hematol 82 2003 605 611
133. S. Ozen, B. Ferhanoglu, M. Senocak Idiopathic myelofibrosis (agnogenic myeloid metaplasia): Clinicopathological analysis of 32 patients Leuk Res 21 1997 125 131
134. F. Cervantes, A. Pereira, J. Esteve Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis Br J Haematol 97 1997 635 640
135. J.L. Demory, B. Dupriez, P. Fenaux Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases Blood 72 1988 855 859
136. C. Rozman, M. Giralt, E. Feliu Life expectancy of patients with chronic nonleukemic myeloproliferative disorders Cancer 67 1991 2658 2663